You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

ANTHELIOS SX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Anthelios Sx patents expire, and what generic alternatives are available?

Anthelios Sx is a drug marketed by Loreal Usa and is included in one NDA.

The generic ingredient in ANTHELIOS SX is avobenzone; ecamsule; octocrylene. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the avobenzone; ecamsule; octocrylene profile page.

Drug patent expirations by year for ANTHELIOS SX
Recent Clinical Trials for ANTHELIOS SX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Loreal USAPhase 4

See all ANTHELIOS SX clinical trials

US Patents and Regulatory Information for ANTHELIOS SX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Loreal Usa ANTHELIOS SX avobenzone; ecamsule; octocrylene CREAM;TOPICAL 021502-001 Jul 21, 2006 OTC Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ANTHELIOS SX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Loreal Usa ANTHELIOS SX avobenzone; ecamsule; octocrylene CREAM;TOPICAL 021502-001 Jul 21, 2006 ⤷  Try a Trial ⤷  Try a Trial
Loreal Usa ANTHELIOS SX avobenzone; ecamsule; octocrylene CREAM;TOPICAL 021502-001 Jul 21, 2006 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ANTHELIOS SX

See the table below for patents covering ANTHELIOS SX around the world.

Country Patent Number Title Estimated Expiration
Argentina 248083 COMPOSICION COSMETICA FILTRANTE FOTOESTABLE PARA PROTECCION DE LA EPIDERMIS CONTRA LOS RAYOS UV DE LONGITUDES DE ONDA ENTRE 280/380 NM, ESTABILIZACION DE DERIVADOS DE DIBENSOILMETANO FRENTE AL UV. (LIGHT-RESISTANT FILTERING COSMETIC COMPOSITION CONTAINING A UV-A FILTER AND AN ALKYL -G(B), -G(B)-DIPHENYLACRYLATE OR AN ALKYL -G(A)-CYANO--G(B), -G(B)-DIPHENYLACRYLATE) ⤷  Try a Trial
Italy 8367659 ⤷  Try a Trial
Japan S595136 3-BENZYLIDENE-CAMPHOR DERIVATIVE AND USE ⤷  Try a Trial
France 2528420 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 9111989 ⤷  Try a Trial
Australia 574961 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.